| Trends in buprenorphine treatment in the United States, 2009-2018 M Olfson, VS Zhang, M Schoenbaum, M King Jama 323 (3), 276-277, 2020 | 126 | 2020 |
| Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others: Trends in buprenorphine treatment by prescriber specialty-primary care … M Olfson, V Zhang, M Schoenbaum, M King Health Affairs 39 (6), 984-992, 2020 | 56 | 2020 |
| Opioid and benzodiazepine coprescribing in the United States before and after US Food and Drug Administration boxed warning VS Zhang, M Olfson, M King JAMA psychiatry 76 (11), 1208-1210, 2019 | 30 | 2019 |
| Tie decay and dissolution: Contentious prescribing practices in the prescription drug epidemic V Zhang, MD King Organization Science 32 (5), 1149-1173, 2021 | 14 | 2021 |
| Changes in buprenorphine treatment after medicaid expansion M Olfson, V Zhang, M King, R Mojtabai Psychiatric Services 72 (6), 633-640, 2021 | 13 | 2021 |
| Where is all the deviance? Liminal prescribing and the social networks underlying the prescription drug crisis V Zhang, AC Mohliver, M King Administrative Science Quarterly 68 (1), 228-269, 2023 | 8 | 2023 |
| Ethics at the fringe: Using novel methods & data to answer imperative questions in behavioral ethics JN Bundy, KA DeCelles, KN Leavitt, L Pierce, S Zhang, T Watkins Academy of management proceedings 2019 (1), 17354, 2019 | 1 | 2019 |
| Makers and Breakers: An Examination of Social Norm Emergence and Deviance in Organizations D Feiler, H Shepherd, S Zhang Academy of Management Proceedings 2021 (1), 14129, 2021 | | 2021 |
| The Social Construction of Organizational Deviance: A Multi-Actor View JN Bundy, MH McDonnell, R Pichler, S Zhang Academy of Management Proceedings 2021 (1), 11455, 2021 | | 2021 |
| Networks and Professional Deviance in the Prescription Drug Abuse Epidemic S Zhang, M King Academy of Management Proceedings 2017 (1), 16365, 2017 | | 2017 |
